Fourth quarter of 2025Net sales in the fourth quarter amounted to SEK 3,224 (3,192) million. Organic growth was 3 per cent and growth from acquisitions ...
In 2026 international oncology continues to move towards personalized medicine, high-precision diagnostics and advanced therapies. More and more patients are considering treatment abroad, focusing on ...
Q4 sales & FY 2025 resultsSequential sales growth improvement in Q4 in all geographiesMeeting or exceeding all full-year objectives Axelerate 2028 implementation and deeper productivity initiatives be ...
And what's going on with SaaS stocks?
Hinge Health, Inc. (NYSE:HNGE) Q4 2025 Earnings Call Transcript February 10, 2026 Hinge Health, Inc. beats earnings expectations. Reported EPS is $0.3797, expectations were $0.04. Operator: Ladies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results